1 | Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants. (Mauskopf J, Chirila C, Graham J, Gersten ID, Leather H, Maziarz RT, Baden LR, Bolaños-Meade J, Brown JM, Walsh TJ, Horowitz MH, Kurtzberg J, Marr KA, Wingard JR) Am J Health Syst Pharm 2013 Sep 01;70(17):1518-27 13 Citations |
2 | The use of group sequential designs with common competing risks tests. (Logan BR, Zhang MJ) Stat Med 2013 Mar 15;32(6):899-913 12 Citations |
1 | Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants. (Aziz M, Patel AL, Losavio J, Iyengar A, Berven M, Schloemer N, Jakubowicz A, Mathai T, McAuley JB) Pediatr Infect Dis J 2010 Apr;29(4):352-6 27 Citations |
1 | Fluconazole and Candida krusei fungemia. (Girmenia C, Pagano L, Leone G, Martino P) Arch Intern Med 2001 Oct 08;161(18):2267-9 7 Citations |
1 | Laryngeal cryptococcus. Treatment with oral fluconazole. (Kerschner JE, Ridley MB, Greene JN) Arch Otolaryngol Head Neck Surg 1995 Oct;121(10):1193-5 14 Citations |